OTCM
DGEN
Market cap0USD
Dec 10, Last price
0.00USD
Name
Deltagen Inc
Chart & performance
P/E
—
P/S
—
EPS
0.00
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
263k
-74.27%
Net income
76k
P
CFO
90k
P
Dividend
May 17, 20070.05 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1999 and is headquartered in San Mateo, California.
Key people
Constantine Anagnostopoulos
Chairman of the Board · since 2002
Larry Hill
Chief Executive Officer · since 2003
Daniel Ratto
Chief Financial Officer · since 2003
Geoffrey Yarranton
Executive Vice President of Research and Development · since 2002
John Burke
Senior Vice President-Intellectual Property, General Counsel · since 2001
Donald Karanewsky
Senior Vice President and New Site Director of Deltagen Research Laboratories · since 2002
Augustine Yee
Senior Vice President-Corporate Development, Secretary · since 2001
Terry Coley
Vice President of Information Technology · since 1999
Mark Moore
Chief Scientific Officer and Treasurer · since 1997
Peter Myers
Executive Vice President of Deltagen Research Laboratories · since 2002
Director · since 2002
Thomas Penn
Director · since 2000
Director · since 2001
Valuation
No data to show